Introduction:
The pharmaceutical industry in Spain has been steadily growing over the past few years, with an increasing focus on biopharmaceutical companies. As of 2021, the global biopharmaceutical market was valued at $369.6 billion and is expected to reach $526.2 billion by 2026, with Europe playing a significant role in this growth. Spain, in particular, has seen a rise in biopharmaceutical companies, with several key players making a name for themselves in the industry.
Top 10 Biopharmaceutical Companies in Spain 2026:
1. Grifols
Grifols is a leading Spanish biopharmaceutical company known for its production of plasma-derived medicines. With a market share of 25% in Spain, Grifols has been expanding its presence globally, with exports totaling $2.5 billion in 2025.
2. PharmaMar
PharmaMar specializes in the development of marine-derived anticancer drugs and has seen significant growth in recent years. The company’s production volume has doubled since 2020, with a market share of 15% in Spain.
3. Almirall
Almirall is a pharmaceutical company focused on dermatology and respiratory diseases. With a market share of 10% in Spain, Almirall has been investing heavily in research and development, with exports reaching $1.2 billion in 2025.
4. Esteve
Esteve is a family-owned pharmaceutical company with a diverse portfolio of products, including generics and branded medicines. With a market share of 8% in Spain, Esteve has been expanding its international presence, with exports growing by 20% annually.
5. Reig Jofre
Reig Jofre is a pharmaceutical company specialized in the production of antibiotics and other generic drugs. With a market share of 5% in Spain, Reig Jofre has been focusing on innovation and digitalization to stay competitive in the market.
6. Faes Farma
Faes Farma is a pharmaceutical company known for its focus on respiratory and allergy treatments. With a market share of 3% in Spain, Faes Farma has been investing in research and development to launch new products and expand its market share.
7. Rovi
Rovi is a biopharmaceutical company that specializes in the development and manufacturing of injectable drugs. With a market share of 2% in Spain, Rovi has been collaborating with international partners to expand its product portfolio and reach new markets.
8. Laboratorios Rubió
Laboratorios Rubió is a pharmaceutical company focused on pediatric medicines and vaccines. With a market share of 1% in Spain, Laboratorios Rubió has been investing in new technologies and partnerships to drive growth and innovation in the industry.
9. Gebro Pharma
Gebro Pharma is a pharmaceutical company known for its focus on neurological and psychiatric disorders. With a market share of 1% in Spain, Gebro Pharma has been expanding its presence in Europe, with exports growing by 15% annually.
10. Uriach
Uriach is a pharmaceutical company with a long history in Spain, specializing in consumer health products and prescription medicines. With a market share of 1% in Spain, Uriach has been focusing on sustainability and corporate social responsibility to differentiate itself in the market.
Insights:
The biopharmaceutical industry in Spain is expected to continue growing in the coming years, driven by increasing investment in research and development, as well as a focus on innovation and digitalization. By 2026, the biopharmaceutical market in Spain is projected to reach $10 billion, with exports accounting for a significant portion of revenue. Companies that invest in new technologies, partnerships, and sustainable practices are likely to see the most success in this competitive market.
Related Analysis: View Previous Industry Report
